CollPlant Biotechnologies (CLGN) Current Leases (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Current Leases came in at $814000.0 in Q4 2025, up 0.99% YoY from $806000.0 in Q4 2024, and down 2.75% on a QoQ basis from $837000.0 in Q2 2025.
CollPlant Biotechnologies (CLGN) Current Leases (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 8 years of Current Leases data on file, last reported at $814000.0 in Q4 2025.
- Quarterly Current Leases rose 0.99% year-over-year to $814000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $814000.0 (up 0.99% YoY) and the FY2025 annual result came in at $814000.0, up 0.99% from the prior year.
- Current Leases retreated to $814000.0 in Q4 2025, from $837000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $837000.0 in Q2 2025 to a low of $477000.0 in Q2 2022.
- A 5-year average of $664400.0 and a median of $637500.0 in 2021 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2021 — Current Leases jumped 47.29% — and 2022, when it dropped 26.73%.
- Tracing CLGN's Current Leases over 5 years: stood at $519000.0 in 2021, then increased by 1.93% to $529000.0 in 2022, then increased by 17.96% to $624000.0 in 2023, then increased by 29.17% to $806000.0 in 2024, then increased by 0.99% to $814000.0 in 2025.
- The last three Current Leases figures came in at $814000.0 (Q4 2025), $837000.0 (Q2 2025), and $806000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 814,000.00 |
| Jun 30, 2025 | 837,000.00 |
| Dec 31, 2024 | 806,000.00 |
| Jun 30, 2024 | 789,000.00 |
| Dec 31, 2023 | 624,000.00 |
| Jun 30, 2023 | 598,000.00 |
| Dec 31, 2022 | 529,000.00 |
| Jun 30, 2022 | 477,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Jun 30, 2021 | 651,000.00 |
| Dec 31, 2020 | 440,000.00 |
| Jun 30, 2020 | 442,000.00 |
| Dec 31, 2019 | 455,000.00 |
| Sep 30, 2019 | 9.12 Mn |
| Jun 30, 2019 | 5.93 Mn |
| Mar 31, 2019 | 5.84 Mn |
| Dec 31, 2018 | 7.17 Mn |
| Sep 30, 2018 | 4.20 Mn |
| Jun 30, 2018 | 4.22 Mn |
| Mar 31, 2018 | 17.76 Mn |